Table 6.
Items | Treatments1 |
SEM |
P value |
||||||
---|---|---|---|---|---|---|---|---|---|
Control | GAA600 | CrN300 | CrN600 | CrN900 | ANOVA | Linear2 | Quadratic2 | ||
Glycolytic parameters | |||||||||
Glycogen (μmol/g) | 5.26b | 5.54b | 5.15b | 6.34a | 6.53a | 0.14 | 0.001 | <0.001 | 0.513 |
Lactic acid (μmol/g) | 131.42a | 126.34ab | 130.79a | 125.43b | 125.56b | 0.85 | 0.042 | 0.010 | 0.844 |
GP (μmol/g) | 141.94 | 137.42 | 141.08 | 138.11 | 138.62 | 0.81 | 0.321 | 0.132 | 0.717 |
Activities of glycolytic enzymes | |||||||||
HK (U/mg of protein) | 14.44 | 12.34 | 13.88 | 12.51 | 11.67 | 0.69 | 0.722 | 0.208 | 0.936 |
PFK (U/mg of protein) | 56.93a | 53.59a | 52.80a | 47.61b | 45.66b | 0.92 | <0.001 | <0.001 | 0.480 |
PK (U/g of protein) | 51.76a | 38.92b | 36.18b | 34.99b | 38.93b | 1.48 | 0.001 | 0.002 | 0.001 |
LDH (U/mg of protein) | 4.30a | 3.61ab | 3.08b | 3.15b | 2.97b | 0.13 | 0.003 | 0.001 | 0.044 |
Abbreviations: GP, glycolytic potential (GP = 2 × [glycogen] + [lactic acid]); HK, hexokinase; LDH, lactate dehydrogenase; PFK, phosphofructokinase; PK, pyruvate kinase.
Different letters in the mean value of the same row indicate a significant difference (P < 0.05). The data are represented as the mean value and pooled SEM (n = 6).
Control, basal diet; GAA600, basal diet supplemented with 600 mg/kg guanidinoacetic acid (GAA); CrN300, CrN600, and CrN900, basal diets supplemented with 300, 600, and 900 mg/kg CrN, respectively.
Orthogonal polynomials were used to estimate the linear and quadratic effects of dietary CrN supplementation among the control, CrN300, CrN600, and CrN900 groups.